Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation

NCT00066469 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoproliferative Disorder

Interventions

BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: methylprednisolone
DRUG: prednisone

Sponsor

Children's Oncology Group

Collaborators

[object Object]